Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity

Award Number: R01DK140477
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/13/2025
PERIOD OF PERFORMANCE END DATE: 06/30/2030

Group Awards By:

View Award Description

Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity - ABSTRACT The alarming rise in the rates of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) persists despite efforts to address contributing factors and promote dietary changes. One major challenge has been the inconsistency in dietary guidelines, especially regarding the role of fructose. While population studies have linked excessive fructose consumption to conditions like type 2 diabetes and NAFLD, questions linger about the precise impact of fructose and whether its effects vary between individuals with and without obesity. The mechanisms underlying these associations remain unclear, particularly in humans. For instance, studies using tracers have shown that fructose consumption is linked to increased rates of fatty acid synthesis (de novo lipogenesis (DNL)), but this effect appears to depend on factors such as the amount of fructose and how it is consumed. In this grant, we will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis, GNG) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. Additionally, we will investigate whether this protective effect of the intestine is impaired in individuals with obesity, potentially making them more vulnerable to fructose consumption. To address these questions, we will conduct four one-day dietary studies in adults with and without obesity. Our study is based on the idea that uncontrolled flux of fructose to the liver, resulting from fructose consumption, is a key factor in the dysregulation of lipid and carbohydrate metabolism. We will employ a feeding approach using well-defined liquid meals and a combination of stable isotopes (non-radioactive tracers), administered orally and intravenously in trace amounts. This approach will enable us to simultaneously measure the fluxes in intestinal GNG, hepatic GNG, and DNL pathways in response to both low and high fructose intake. We will also explore whether these fluxes differ between individuals with obesity and lean controls. By concurrently assessing these pathways, our proposal has the potential to advance our understanding of postprandial fructose metabolism and offer critical mechanistic insights to support evidence-based dietary recommendations, particularly concerning more targeted limitations in fructose consumption.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $730,498 )
2025	2025	TOURO UNIVERSITY	1310 CLUB DR	VALLEJO	CA	94592	SOLANO	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	8/12/2025	NEW	$730,498
														Subtotal = $730,498

Grand Total All Awards = $730,498

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity

Award Number: R01DK140477

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/13/2025

PERIOD OF PERFORMANCE END DATE: 06/30/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer